@hoperugo.bsky.social
which covered ongoing trials combining ADCs with immunotherapy as well as two novel bi-specific (two targets!) antibodies showing promise. I learned so much!
#OncoAlertColloquium #BreastCancer
@hoperugo.bsky.social
which covered ongoing trials combining ADCs with immunotherapy as well as two novel bi-specific (two targets!) antibodies showing promise. I learned so much!
#OncoAlertColloquium #BreastCancer
bit.ly/3tEqyP9
bit.ly/3tEqyP9
#SABCS2024 #bcsm
#SABCS2024 #bcsm